Catalyst Biosciences to Host Key Opinion Leader Meeting on Next-Generation Subcutaneous Factor VIIa Marzeptacog Alfa (Activated) in Patients with Bleeding Disorders on August 15

August 8, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search